PT1041990E - COMPOSITION FOR THE TREATMENT OF RESPIRATORY DISEASES AND SKIN DISEASES, COMPREHENDING AT LEAST A LEUCOTRIENE ANTAGONIST AND AT LEAST AN ANTIHISTAMINIC - Google Patents
COMPOSITION FOR THE TREATMENT OF RESPIRATORY DISEASES AND SKIN DISEASES, COMPREHENDING AT LEAST A LEUCOTRIENE ANTAGONIST AND AT LEAST AN ANTIHISTAMINICInfo
- Publication number
- PT1041990E PT1041990E PT98963828T PT98963828T PT1041990E PT 1041990 E PT1041990 E PT 1041990E PT 98963828 T PT98963828 T PT 98963828T PT 98963828 T PT98963828 T PT 98963828T PT 1041990 E PT1041990 E PT 1041990E
- Authority
- PT
- Portugal
- Prior art keywords
- diseases
- comprehending
- antihistaminic
- treatment
- composition
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/10—Expectorants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/12—Mucolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/14—Antitussive agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Pain & Pain Management (AREA)
- Immunology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Rheumatology (AREA)
- Otolaryngology (AREA)
- Biomedical Technology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US6863897P | 1997-12-23 | 1997-12-23 | |
US7863898P | 1998-03-19 | 1998-03-19 |
Publications (1)
Publication Number | Publication Date |
---|---|
PT1041990E true PT1041990E (en) | 2006-10-31 |
Family
ID=26749192
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PT98963828T PT1041990E (en) | 1997-12-23 | 1998-12-21 | COMPOSITION FOR THE TREATMENT OF RESPIRATORY DISEASES AND SKIN DISEASES, COMPREHENDING AT LEAST A LEUCOTRIENE ANTAGONIST AND AT LEAST AN ANTIHISTAMINIC |
Country Status (27)
Country | Link |
---|---|
EP (1) | EP1041990B1 (en) |
JP (2) | JP2001526232A (en) |
KR (1) | KR100737710B1 (en) |
CN (1) | CN1283115A (en) |
AR (1) | AR017224A1 (en) |
AT (1) | ATE331522T1 (en) |
AU (1) | AU758771B2 (en) |
BR (1) | BR9814417A (en) |
CA (1) | CA2315721C (en) |
CO (1) | CO4980868A1 (en) |
CZ (1) | CZ301349B6 (en) |
DE (1) | DE69835103T2 (en) |
DK (1) | DK1041990T3 (en) |
ES (1) | ES2263229T3 (en) |
HK (1) | HK1027502A1 (en) |
HU (1) | HUP0101369A3 (en) |
ID (1) | ID26390A (en) |
IL (1) | IL136461A0 (en) |
MY (1) | MY121744A (en) |
NO (1) | NO20003288L (en) |
NZ (1) | NZ520907A (en) |
PE (1) | PE20000126A1 (en) |
PL (1) | PL193131B1 (en) |
PT (1) | PT1041990E (en) |
SA (1) | SA99200013B1 (en) |
SK (1) | SK286103B6 (en) |
WO (1) | WO1999032125A1 (en) |
Families Citing this family (47)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE4394931T1 (en) | 1992-09-03 | 1995-07-20 | Sepracor Inc | Use of norastemizole for the treatment of allergic diseases |
US6303632B1 (en) | 1992-09-03 | 2001-10-16 | Sepracor Inc. | Compositions for treating allergic and other disorders using norastemizole in combination with other active ingredients |
US7214683B1 (en) | 1994-12-30 | 2007-05-08 | Sepracor Inc. | Compositions of descarboethoxyloratadine |
US7211582B1 (en) | 1994-12-30 | 2007-05-01 | Sepracor Inc. | Methods for treating urticaria using descarboethoxyloratadine |
US6384038B1 (en) | 1998-04-14 | 2002-05-07 | Sepracor Inc. | Methods and compositions using cetirizine in combination with leukotriene inhibitors or decongestants |
US6248308B1 (en) | 1998-04-14 | 2001-06-19 | Sepracor Inc. | Methods of using norastemizole in combination with leukotriene inhibitors to treat or prevent asthma |
US6194431B1 (en) | 1998-04-14 | 2001-02-27 | Paul D. Rubin | Methods and compositions using terfenadine metabolites in combination with leukotriene inhibitors |
IT1303671B1 (en) | 1998-07-28 | 2001-02-23 | Nicox Sa | SALTS OF NITRIC ACID WITH ACTIVE DRUGS IN THE TREATMENT OF DISEASES OF THE RESPIRATORY SYSTEM |
EP1000623A1 (en) * | 1998-09-29 | 2000-05-17 | BOEHRINGER INGELHEIM INTERNATIONAL GmbH | Use of epinastine as antitussivum |
EP1118327A4 (en) * | 1998-09-30 | 2006-08-02 | Ono Pharmaceutical Co | Preventive and/or therapeutic agents for sinusitis |
US20020198246A1 (en) | 1998-09-30 | 2002-12-26 | Ono Pharmaceutical Co., Ltd. | Agent for preventing and/or treating sinusitis |
WO2001056571A1 (en) * | 2000-02-03 | 2001-08-09 | Schering Corporation | Treating allergic and inflammatory conditions |
US7405223B2 (en) | 2000-02-03 | 2008-07-29 | Schering Corporation | Treating allergic and inflammatory conditions |
DE10007203A1 (en) | 2000-02-17 | 2001-08-23 | Asta Medica Ag | Composition for treating allergic and/or vasomotor rhinitis or allergic conjunctivitis by topical or oral administration, contains synergistic combination of non-sedating antihistamine and leukotriene antagonist |
JP2002087963A (en) * | 2000-09-08 | 2002-03-27 | Nippon Boehringer Ingelheim Co Ltd | Epinastine-containing tablet produced by direct compression |
US20020094345A1 (en) | 2000-10-06 | 2002-07-18 | Sara Abelaira | Pharmaceutical compositions containing epinastine and pseudoephedrine |
PE20020324A1 (en) * | 2000-10-06 | 2002-06-18 | Boehringer Ingelheim Int | NEW PHARMACEUTICAL COMPOSITIONS CONTAINING EPINASTIN AND PSEUDOEPHEDRINE |
JP4074427B2 (en) * | 2000-12-18 | 2008-04-09 | 株式会社栃木臨床病理研究所 | Preventive or therapeutic agent for endometriosis |
US20020198228A1 (en) * | 2001-04-03 | 2002-12-26 | Kaura Sita R. | Composition and method for the treatment of respiratory desease |
GB0115181D0 (en) * | 2001-06-20 | 2001-08-15 | Glaxo Group Ltd | Novel use |
HUP0401630A2 (en) * | 2001-06-20 | 2004-12-28 | Schering Corp. | Antihistamines use of for preparation of pharmaceutical compositions suitable for the treatment of nasal congestion and nasal obstruction |
IL159287A0 (en) | 2001-06-28 | 2004-06-01 | Ucb Farchim Sa | Tablet comprising cetirizine and pseudoephedrine |
MY148466A (en) | 2001-10-26 | 2013-04-30 | Merck Frosst Canada Ltd | Granule formulation |
WO2003101434A2 (en) * | 2001-12-21 | 2003-12-11 | Sampad Bhattacharya | Intranasal pharmaceutical compositions comprising an antihistamine and a leukotriene inhibitor |
AU2003237253A1 (en) * | 2002-05-29 | 2003-12-19 | Aventis Pharmaceuticals Holdings Inc. | Method of treating asthma using fexofenadine |
DE60319227T2 (en) * | 2002-07-02 | 2009-05-07 | Ucb Farchim S.A. | DIARYLMETHYLPIPERAZINES AS PROPHYLACTIC OR THERAPEUTIC AGENTS AGAINST VIRAL MYOCARDITIS |
EP1569651B1 (en) * | 2002-12-06 | 2008-07-30 | UCB Farchim S.A. | Tablet comprising efletirizine and pseudoephedrine |
WO2004087095A2 (en) * | 2003-03-31 | 2004-10-14 | Osmotica Costa Rica, Sociedad Anonima | Osmotic controlled release device containing zafirlukast and an h1-antagonist |
EP1468696A1 (en) * | 2003-04-17 | 2004-10-20 | Boehringer Ingelheim International GmbH | Combinations of epinastine and antiphlogisitcs as new pharmaceutical compositions for the treatment of skin diseases |
WO2005030331A1 (en) * | 2003-09-26 | 2005-04-07 | Fairfield Clinical Trials, Llc | Combination antihistamine medication |
WO2005089803A2 (en) * | 2004-03-24 | 2005-09-29 | Boehringer Ingelheim International Gmbh | Pharmaceutical compositions for the treatment of skin diseases comprising a combination of epinastine and one or more additional minerals or one or more crude drugs |
TR200806298A2 (en) | 2008-08-22 | 2010-03-22 | Bi̇lgi̇ç Mahmut | Pharmaceutical formulation |
KR20130050952A (en) | 2010-06-16 | 2013-05-16 | 브루스 챈들러 메이 | Use of levocetirizine and montelukast in the treatment of influenza, common cold and inflammation |
JP6051378B2 (en) * | 2011-05-02 | 2016-12-27 | 国立大学法人 熊本大学 | Low molecular weight compound that promotes differentiation induction from stem cells to insulin producing cells, and method for inducing differentiation from stem cells to insulin producing cells using the compounds |
KR20130009553A (en) * | 2011-07-15 | 2013-01-23 | 한미약품 주식회사 | Capsule formulation comprising montelukast or a pharmaceutically acceptable salt thereof, and levocetirizine or a pharmaceutically acceptable salt thereof |
WO2013058527A2 (en) * | 2011-10-18 | 2013-04-25 | 주식회사 네비팜 | Combined formulation of leukotriene antagonist and epinastine |
KR101278572B1 (en) * | 2011-10-18 | 2013-06-25 | 주식회사 네비팜 | Pharmaceutical combinations of leukotriene antagonist and epinastine and their preparing methods |
ES2770760T3 (en) | 2013-03-13 | 2020-07-03 | Inflammatory Response Res Inc | Use of levocetirizine and montelukast in the treatment of traumatic injuries |
AU2014249534B2 (en) | 2013-03-13 | 2018-08-30 | IRR, Inc. | Use of levocetirizine and montelukast in the treatment of vasculitis |
CA2901421A1 (en) | 2013-03-13 | 2014-10-09 | Bruce Chandler May | Use of levocetirizine and montelukast in the treatment of autoimmune disorders |
US9636318B2 (en) * | 2015-08-31 | 2017-05-02 | Banner Life Sciences Llc | Fumarate ester dosage forms |
KR102356601B1 (en) | 2014-06-10 | 2022-01-27 | 지엘팜텍주식회사 | Controlled-release pellet compositions containing pseudoephedrine |
JP2017526728A (en) | 2014-09-15 | 2017-09-14 | インフラマトリー・レスポンス・リサーチ・インコーポレイテッド | Levocetirizine and montelukast in the treatment of inflammation-mediated conditions |
US9981039B2 (en) | 2015-05-29 | 2018-05-29 | Accolade Pharma Llc | Composition, its preparation and method of use in treating skin disorders |
BR112018072177A2 (en) * | 2016-05-17 | 2019-02-12 | Proponent Biotech Gmbh | pharmaceutical composition, container, and methods for treating and preventing nasal congestion, viral respiratory tract infections and / or throat inflammation |
KR20190008235A (en) * | 2016-05-17 | 2019-01-23 | 프로포넌트 바이오테크 게엠베하 | Carboxylic acids for treating / preventing skin diseases |
WO2021142062A1 (en) | 2020-01-10 | 2021-07-15 | Banner Life Sciences Llc | Fumarate ester dosage forms with enhanced gastrointestinal tolerability |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4254129A (en) * | 1979-04-10 | 1981-03-03 | Richardson-Merrell Inc. | Piperidine derivatives |
US4662880A (en) * | 1986-03-14 | 1987-05-05 | Alza Corporation | Pseudoephedrine, brompheniramine therapy |
US4810502A (en) * | 1987-02-27 | 1989-03-07 | Alza Corporation | Pseudoephedrine brompheniramine therapy |
US5276044A (en) * | 1991-08-14 | 1994-01-04 | Allergan, Inc. | Leukotriene receptor antagonist and antihistamine complex pharmaceutical compositions |
ES2165122T3 (en) * | 1992-02-05 | 2002-03-01 | Boehringer Ingelheim Pharma | NEW DERIVATIVES OF AMIDINA, ITS PREPARATION AND USE AS MEDICATIONS WITH ANTAGONIST EFFECT OF LTB4. |
DE4203201A1 (en) * | 1992-02-05 | 1993-08-12 | Boehringer Ingelheim Kg | New amidine derivatives are LTB antagonists - useful for treating allergic disorders e.g. asthma, colitis ulcerosa or psoriasis |
US5270324A (en) * | 1992-04-10 | 1993-12-14 | Merck Frosst Canada, Inc. | Fluorinated hydroxyalkylquinoline acids as leukotriene antagonists |
US5595997A (en) * | 1994-12-30 | 1997-01-21 | Sepracor Inc. | Methods and compositions for treating allergic rhinitis and other disorders using descarboethoxyloratadine |
JPH08325265A (en) * | 1995-05-29 | 1996-12-10 | Fujisawa Pharmaceut Co Ltd | Production of thiazolylbenzofuran derivative, and compound used for the production |
EP0780127A1 (en) * | 1995-12-19 | 1997-06-25 | The Procter & Gamble Company | A nasal spray containing a steroid and a antihistamine |
CA2245162A1 (en) * | 1996-02-08 | 1997-08-14 | Merck & Co., Inc. | Method of treatment and pharmaceutical composition |
EP0954318A1 (en) * | 1996-06-04 | 1999-11-10 | The Procter & Gamble Company | A nasal spray containing an intranasal steroid and an antihistamine |
US5900421A (en) * | 1997-02-11 | 1999-05-04 | Sepracor Inc. | Methods and compositions for treating allergic asthma and dermatitis using descarboethoxyloratadine |
JP2001524108A (en) * | 1997-04-30 | 2001-11-27 | ワーナー−ランバート・カンパニー | Topical nasal anti-inflammatory composition |
-
1998
- 1998-12-21 IL IL13646198A patent/IL136461A0/en not_active IP Right Cessation
- 1998-12-21 DE DE69835103T patent/DE69835103T2/en not_active Expired - Lifetime
- 1998-12-21 KR KR1020007006986A patent/KR100737710B1/en not_active IP Right Cessation
- 1998-12-21 SK SK897-2000A patent/SK286103B6/en not_active IP Right Cessation
- 1998-12-21 EP EP98963828A patent/EP1041990B1/en not_active Expired - Lifetime
- 1998-12-21 HU HU0101369A patent/HUP0101369A3/en unknown
- 1998-12-21 JP JP2000525116A patent/JP2001526232A/en active Pending
- 1998-12-21 AT AT98963828T patent/ATE331522T1/en active
- 1998-12-21 BR BR9814417-0A patent/BR9814417A/en not_active Application Discontinuation
- 1998-12-21 AR ARP980106566A patent/AR017224A1/en not_active Application Discontinuation
- 1998-12-21 AU AU19071/99A patent/AU758771B2/en not_active Ceased
- 1998-12-21 PL PL341343A patent/PL193131B1/en not_active IP Right Cessation
- 1998-12-21 CZ CZ20002198A patent/CZ301349B6/en not_active IP Right Cessation
- 1998-12-21 CA CA002315721A patent/CA2315721C/en not_active Expired - Fee Related
- 1998-12-21 ES ES98963828T patent/ES2263229T3/en not_active Expired - Lifetime
- 1998-12-21 WO PCT/US1998/026223 patent/WO1999032125A1/en not_active Application Discontinuation
- 1998-12-21 MY MYPI98005791A patent/MY121744A/en unknown
- 1998-12-21 DK DK98963828T patent/DK1041990T3/en active
- 1998-12-21 CN CN98812638A patent/CN1283115A/en active Pending
- 1998-12-21 NZ NZ520907A patent/NZ520907A/en not_active IP Right Cessation
- 1998-12-21 PT PT98963828T patent/PT1041990E/en unknown
- 1998-12-21 ID IDW20001217A patent/ID26390A/en unknown
- 1998-12-22 CO CO98075939A patent/CO4980868A1/en unknown
- 1998-12-22 PE PE1998001265A patent/PE20000126A1/en not_active Application Discontinuation
-
1999
- 1999-04-20 SA SA99200013A patent/SA99200013B1/en unknown
-
2000
- 2000-06-22 NO NO20003288A patent/NO20003288L/en not_active Application Discontinuation
- 2000-10-13 HK HK00106523A patent/HK1027502A1/en not_active IP Right Cessation
-
2010
- 2010-12-27 JP JP2010291255A patent/JP2011068679A/en not_active Withdrawn
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PT1041990E (en) | COMPOSITION FOR THE TREATMENT OF RESPIRATORY DISEASES AND SKIN DISEASES, COMPREHENDING AT LEAST A LEUCOTRIENE ANTAGONIST AND AT LEAST AN ANTIHISTAMINIC | |
EE200000503A (en) | Method for the preparation of a pharmaceutical composition of topiramate, a pharmaceutical composition and the use of topiramate in the manufacture of a medicament for the treatment of diabetes | |
ATE318590T1 (en) | DRUG COMBINATIONS (E.G. CHLORPROMAZINE AND PENTAMIDINE) FOR THE THERAPY OF NEOPLASTIC DISEASES | |
PT730864E (en) | MEDICATION FOR TREATING HEART DISEASE DISEASES | |
PT966436E (en) | ARILSULFONAMIDES AND ANALOGS AND THEIR APPLICATION FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES | |
DE69600065D1 (en) | Dermatological and / or pharmaceutical preparation, its manufacture and use | |
BR9604959A (en) | Composition and method for the treatment of tooth desensitization | |
ITRM920412A1 (en) | HETEROPROSTANOIDS, PROCEDURE FOR THEIR PREPARATION AND THERAPEUTIC USE. | |
BR9707588A (en) | Therapeutic agent for diabetes | |
EE04493B1 (en) | Cyclopentene derivatives, a pharmaceutical composition containing them and their use as a medicament for the treatment of motilin receptor-related disorders in humans | |
BR9711421B1 (en) | Skin care composition. | |
PT928193E (en) | USE OF 1-HYDROXY-2-PYRIDONES FOR THE TREATMENT OF SKIN INFECTIONS | |
BR9605702A (en) | Alourante for human hair | |
PT983275E (en) | NEW DERIVATIVES OF TRIPTOLIDO ADVANTAGES FOR THE TREATMENT OF AUTOMATIC DISEASES | |
FI964619A (en) | Dosage of antiepileptic drugs on the skin | |
ID23528A (en) | THERAPEUTIC TREATMENT FOR SKIN DISORDERS | |
BR9508896A (en) | Scented composition for topical skin treatment | |
BR9507732A (en) | Pharmaceutical composition for the treatment of glaucoma | |
DE69816580D1 (en) | Triazole derivatives or salts thereof, manufacturing processes and intermediates therefor and pharmaceutical preparations | |
DE69722178D1 (en) | THERAPEUTIC ACTIVE SUBSTANCE FOR EYE DISEASES | |
BR9808216B1 (en) | pharmaceutical or cosmetic composition comprising retinoid with melibiosis, use thereof and method for the cosmetic treatment of changes associated with aging skin and / or exoskeleton. | |
SE9803276D0 (en) | Use of certain drugs for treating nerve root injury | |
BR9402638A (en) | Comsetic composition for skin care | |
BR9604891A (en) | Levopubivacaine and its use as an anesthetic for pregnant women | |
BR7201475U (en) | MACHINE FOR THE MANUFACTURE OF ABSORBENTS, FRAUD AND SIMILAR |